Karanjin from Pongamia pinnata induces GLUT4 translocation in skeletal muscle cells in a phosphatidylinositol-3-kinase-independent manner

European Journal of Pharmacology
Natasha JaiswalAkhilesh Kumar Tamrakar


Insulin-stimulated glucose uptake in skeletal muscle is decreased in type 2 diabetes due to impaired translocation of insulin-sensitive glucose transporter 4 (GLUT4) from intracellular pool to plasma membrane. Augmenting glucose uptake into this tissue may help in management of type 2 diabetes. Here, the effects of an identified antihyperglycemic molecule, karanjin, isolated from the fruits of Pongamia pinnata were investigated on glucose uptake and GLUT4 translocation in skeletal muscle cells. Treatment of L6-GLUT4myc myotubes with karanjin caused a substantial increase in the glucose uptake and GLUT4 translocation to the cell surface, in a concentration-dependent fashion, without changing the total amount of GLUT4 protein and GLUT4 mRNA. This effect was associated with increased activity of AMP-activated protein kinase (AMPK). Cycloheximide treatment inhibited the effect of karanjin on GLUT4 translocation suggesting the requirement of de novo synthesis of protein. Karanjin-induced GLUT4 translocation was further enhanced with insulin and the effect is completely protected in the presence of wortmannin. Moreover, karanjin did not affect the phosphorylation of AKT (Ser-473) and did not alter the expression of the key molecules ...Continue Reading


Mar 1, 1992·Diabetes Care·R A DeFronzoE Ferrannini
Sep 1, 1989·Diabetes Care·C J Bailey, C Day
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·K Suzuki, T Kono
May 13, 1999·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·M KellererH U Häring
Feb 5, 2004·Phytochemistry·Prem P YadavRakesh Maurya
Mar 25, 2005·Biochemical Society Transactions·G I WelshJ M Tavaré
Mar 17, 2006·Trends in Biochemical Sciences·Robert T Watson, Jeffrey E Pessin
Apr 4, 2007·Cell Metabolism·Shaohui Huang, Michael P Czech
May 1, 2007·Drug Discovery Today·Sheng Zhang, Zhong-Yin Zhang
Feb 16, 2008·Drug Discovery Today·Arvind Saklani, Samuel K Kutty
Jun 24, 2008·The Biochemical Journal·Hilal ZaidAmira Klip
Jun 24, 2008·Journal of Ethnopharmacology·Akhilesh Kumar TamrakarArvind Kumar Srivastava
Nov 4, 2008·Trends in Molecular Medicine·Ricardo LageMiguel López
Oct 6, 2009·Journal of the American Pharmacists Association : JAPhA·R Keith Campbell
Sep 8, 2010·European Journal of Pharmacology·Yu-Chuan HuangTsu-Chung Chang
Oct 12, 2010·Endocrinology·Akhilesh Kumar TamrakarAmira Klip
Apr 19, 2011·Molecular and Cellular Endocrinology·Akhilesh Kumar TamrakarArvind Kumar Srivastava


Feb 24, 2016·Acta Pharmaceutica Sinica. B·David Grahame Hardie
Apr 16, 2014·The Journal of Pharmacy and Pharmacology·Mohamed EddouksNaoufel Ali Zeggwagh
Sep 11, 2013·Journal of Ethnopharmacology·L M R Al MuqarrabunI Sahidin
Jun 26, 2020·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·Jingyu ZhangCheng Wang
Jan 10, 2021·Phytochemistry·A SinghL Rangan

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.